Acquired hepatocerebral degeneration
- PMID: 21496578
- DOI: 10.1016/B978-0-444-52014-2.00011-2
Acquired hepatocerebral degeneration
Abstract
Repeated episodes of liver failure or chronic liver cirrhosis may cause acquired (non-Wilsonian) hepatocerebral degeneration (AHCD). Patients with AHCD may show cognitive deficits, ataxia, dysarthria, movement disorders, including parkinsonism, and sometimes myelopathy. Various parenchymal and cholestatic hepatic disorders may result in AHCD. Most patients with AHCD have evidence of portosystemic shunting without necessarily having abnormal liver function. Recent evidence suggests manganese plays a crucial role in the pathogenesis of AHCD. Excess dietary manganese is rapidly cleared by the liver before reaching the systemic circulation. In patients with cirrhosis and portosystemic shunting, manganese bypasses the liver and accumulates in the internal pallidum, while serum manganese levels may be normal or increased. Magnetic resonance imaging abnormalities mainly consist of a signal hyperintensity on T1-weighted images in the internal pallidum. It may also be seen in the putamen, the caudate nucleus, the capsula interna, the mesencephalon, and the cerebellum, and is believed to reflect local manganese accumulation. No specific treatment of AHCD exists. Controlled studies are lacking, but case reports have stressed the usefulness of branched-chain amino acid therapy, trientine, and liver transplantation for the treatment of movement disorders. Levodopa may be efficacious in the treatment of AHCD parkinsonism.
Copyright © 2011 Elsevier B.V. All rights reserved.
Similar articles
-
Acquired hepatocerebral degeneration in hepatitis C infection.J Coll Physicians Surg Pak. 2005 Feb;15(2):110-1. J Coll Physicians Surg Pak. 2005. PMID: 15730841
-
Prominent cerebellar symptoms with unusual magnetic resonance imaging findings in acquired hepatocerebral degeneration.Arch Neurol. 2004 Sep;61(9):1458-60. doi: 10.1001/archneur.61.9.1458. Arch Neurol. 2004. PMID: 15364694
-
Transient improvement of acquired hepatocerebral degeneration with parkinsonian symptoms after failed liver transplant: case report and literature review.Exp Clin Transplant. 2011 Dec;9(6):363-9. Exp Clin Transplant. 2011. PMID: 22142042 Review.
-
Acquired hepatocerebral degeneration: clinical characteristics and MRI findings.Eur J Neurol. 2010 Dec;17(12):1463-70. doi: 10.1111/j.1468-1331.2010.03076.x. Eur J Neurol. 2010. PMID: 20491897
-
Recent Updates on Acquired Hepatocerebral Degeneration.Tremor Other Hyperkinet Mov (N Y). 2017 Sep 5;7:463. doi: 10.7916/D8TB1K44. eCollection 2017. Tremor Other Hyperkinet Mov (N Y). 2017. PMID: 28975044 Free PMC article. Review.
Cited by
-
Role of hepatitis c virus in hepatocellular carcinoma and neurological disorders: an overview.Front Oncol. 2022 Jul 29;12:913231. doi: 10.3389/fonc.2022.913231. eCollection 2022. Front Oncol. 2022. PMID: 35965577 Free PMC article. Review.
-
Neuroinflammation and white matter alterations in occupational manganese exposure assessed by diffusion basis spectrum imaging.Neurotoxicology. 2023 Jul;97:25-33. doi: 10.1016/j.neuro.2023.04.013. Epub 2023 Apr 29. Neurotoxicology. 2023. PMID: 37127223 Free PMC article.
-
Atypical neuroimaging findings in patients with acquired hepatocerebral degeneration.Neurol Sci. 2020 Jan;41(1):175-181. doi: 10.1007/s10072-019-04068-y. Epub 2019 Sep 7. Neurol Sci. 2020. PMID: 31494818
-
Chronic acquired hepatocerebral degeneration presenting with Meige's syndrome and behavioral symptoms fully reversed by liver transplantation.Neurol Sci. 2021 Nov;42(11):4755-4758. doi: 10.1007/s10072-021-05475-w. Epub 2021 Jul 19. Neurol Sci. 2021. PMID: 34278516
-
Management of Neurologic Manifestations in Patients with Liver Disease.Curr Treat Options Neurol. 2016 Aug;18(8):37. doi: 10.1007/s11940-016-0419-0. Curr Treat Options Neurol. 2016. PMID: 27314429 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
